en · de · es · pt
peptide-index.peptides5388.com › Blog › Analytical Detection And Stability — Beginner to Advanced

Analytical Detection And Stability — Beginner to Advanced

By Editorial Desk · published 2025-12-16 · last reviewed 2026-01-19 · Blog

LC-MS raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

Reviewed 2026-01-19. Anything still debated is marked as such rather than presented as settled.

Analytical Detection and Stability

Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.

Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.

Background and Pharmacological Mechanism

Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.

SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.

Sr9009 at a glance

PropertyValueNotes
Common synonymsSR9009; StenabolicNickname is not a chemical name.
Typical analytical methodLC-MS/MSOften with isotope-labeled internal standard.
Storage temperature-20 °CDesiccated and protected from light.
Solution stabilityDMSO stock; avoid freeze-thawStore at -20 to -80 °C.
Regulatory statusNot approved; varies by countryMay be restricted as research chemical.

Background and Mechanism

Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.

At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.

Related pages on this site

Identity, Handling, and Regulation

Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.

Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.

Background from the literature

== Presence in space == The presence of glycine outside the Earth was confirmed in 2009, based on the analysis of samples that had been taken in 2004 by the NASA spacecraft Stardust from comet Wild 2 and subsequently returned to Earth. Glycine had previously been identified in the Murchison meteorite in 1970. The discovery of glycine in outer space bolstered the hypothesis of so-called soft-panspermia, which claims that the "building blocks" of life are widespread throughout the universe. In 2016, detection of glycine within Comet 67P/Churyumov–Gerasimenko by the Rosetta spacecraft was announced. The detection of glycine outside the Solar System in the interstellar medium has been debated.

==== Absorption of HMB-Ca ==== After ingestion, HMB-Ca is converted to β-hydroxy β-methylbutyrate following dissociation in the gut. When the HMB-Ca dosage form is ingested, the magnitude and time at which the peak plasma concentration of HMB occurs depends on the dose and concurrent food intake. Higher HMB-Ca doses increase the rate of absorption, resulting in a peak plasma HMB level (Cmax) that is disproportionately greater than expected of a linear dose-response relationship and which occurs sooner relative to lower doses. Consumption of HMB-Ca with sugary substances slows the rate of HMB absorption, resulting in a lower peak plasma HMB level that occurs later.

== Saturation of the gastric ATPase == Even though consumption of food stimulates acid secretion and acid secretion activates PPIs, PPIs cannot inhibit all pumps. About 70% of pump enzyme is inhibited, as PPIs have a short half-life and not all pump enzymes are activated. It takes about 3 days to reach steady-state inhibition of acid secretion, as a balance is struck between covalent inhibition of active pumps, subsequent stimulation of inactive pumps after the drug has been eliminated from the blood, and de novo synthesis of new pumps.

=== Generalised time reversible === Generalised time reversible (GTR) is the most general neutral, independent, finite-sites, time-reversible model possible. It was first described in a general form by Simon Tavaré in 1986. The GTR model is often called the general time reversible model in publications; it has also been called the REV model. The GTR parameters for nucleotides consist of an equilibrium base frequency vector,

Sources: en.wikipedia.org

Reference notes

== Human and mouse genes == The genes encoding human 5-HT3 receptors are located on chromosomes 11 (HTR3A, HTR3B) and 3 (HTR3C, HTR3D, HTR3E), so it appears that they have arisen from gene duplications. The genes HTR3A and HTR3B encode the 5-HT3A and 5-HT3B subunits and HTR3C, HTR3D and HTR3E encode the 5-HT3C, 5-HT3D and 5-HT3E subunits. HTR3C and HTR3E do not seem to form functional homomeric channels, but when co-expressed with HTR3A they form heteromeric complex with decreased or increased 5-HT efficacies. The pathophysiological role for these additional subunits has yet to be identified. The human 5-HT3A receptor gene is similar in structure to the mouse gene which has 9 exons and is spread over ~13 kb. Four of its introns are exactly in the same position as the introns in the homologous α7-acetylcholine receptor gene, clearly showing their evolutionary relationship.

The medication is used to treat clear cell renal cell carcinoma, the most common histological subtype. The treatment phase is continuing treatment beyond three months. The patient has been issued an authority prescription for pazopanib. The patient must have stable or responding disease according to the Response Evaluation Criteria In Solid Tumours (RECIST). This treatment must be the sole tyrosine kinase inhibitor subsidised for this condition. Pazopanib has also demonstrated initial therapeutic properties in patients with aggressive fibromatosis (desmoid tumor), ovarian and non-small cell lung cancer. However, plans to apply to the EMA for a variation to include advanced ovarian cancer have been withdrawn and a license will not be sought in any country.

=== Related prokaryotic systems === Gene expression in prokaryotes is influenced by an RNA-based system similar in some respects to RNAi. Here, RNA-encoding genes control mRNA abundance or translation by producing a complementary RNA that anneals to an mRNA. However these regulatory RNAs are not generally considered to be analogous to miRNAs because the Dicer enzyme is not involved. It has been suggested that CRISPR interference systems in prokaryotes are analogous to eukaryotic RNAi systems, although none of the protein components are orthologous.

While most hormonal therapy strategies seek to block hormone signalling to cancer cells, there are some instances in which supplementation with specific hormone agonists may have a growth-inhibiting, or even cytotoxic effect on tumor cells. Because many hormones can produce antagonism and feedback inhibition of the synthesis of other hormones, there is significant overlap between this concept and those discussed above.

=== Class I: Cys-based PTPs === Class I PTPs constitute the largest family. They contain the well-known classical receptor (a) and non-receptor PTPs (b), which are strictly tyrosine-specific, and the DSPs (c) which target Ser/Thr as well as Tyr and are the most diverse in terms of substrate specificity.

Sources: en.wikipedia.org

Reference notes

=== David Healy === David Maurice Healy is played by Johnny Galecki. David is Mark Healy's younger brother. He first appeared in "The Bowling Show" (episode 4.14). Whereas Mark was initially a rebellious delinquent, David is friendly and respectful to the Conners. He is shy, polite, thoughtful, sensitive, soft-spoken, artistic, and intelligent. Much of his passive behavior results from his difficult home life and his mother's abusive behavior. He is romantically involved with Darlene, becoming the submissive partner. They also collaborate artistically, with David illustrating graphic novels that Darlene writes. His sweet manner endears him to the Conners, who eventually consider him as part of the family and jokingly refer to him as being more welcome than Darlene. He moves in with the Conners after Roseanne, herself a victim of child abuse, witnesses how abusive David's mother is. David and Darlene break up three times throughout the series, each for a successively longer period of time, but always reunite. After Darlene becomes pregnant, she and David married. In the series finale, Roseanne reveals in her writing that David had actually been dating Becky in "real life", and that Roseanne simply wrote his relationship as being with Darlene because she felt it made more sense. The series finale is retconned for season 10, where it is revealed that David and Darlene have been separated for some years and David has been away, traveling and doing volunteer work abroad, leaving Darlene to raise their two children, Harris and Mark, as a single mother.

This rearrangement demonstrates that similar to the Michaelis–Menten equation, the maximal rate of reaction depends on the proportion of the enzyme population interacting with its substrate. fraction of the enzyme population bound by substrate

Both Agincourt Collegiate Institute and R. H. King Academy claim to be the oldest secondary schools in the district. Agincourt Collegiate Institute (the former Agincourt Continuation School) opened in 1915. It became a high school in 1954. R. H. King Academy opened in 1922 as the Scarborough High School being the first high school in the Scarborough area at that time, and became a collegiate in 1930. Four public school boards operate primary and secondary schools in the district: Conseil scolaire catholique MonAvenir (CSCM), Conseil scolaire Viamonde (CSV), the Toronto Catholic District School Board (TCDSB), and the Toronto District School Board (TDSB). CSV and TDSB operate as secular public school boards, the former operating French first language institutiona, whereas the latter operates English first language institutions. The other two school boards, CSCM and TCDSB, operate as public separate school boards, the former operating French first-language separate schools, the latter operating English first-language separate schools. As of 2008, there are 28 secondary schools in Scarborough. In addition to primary and secondary schools, two post-secondary institutions are located in Scarborough. The University of Toronto maintains a Scarborough campus, established in 1964, which has an enrolment of more than 15,000 students as of 2024. Centennial College was opened in 1966. It was the first vocational college to open in Ontario. Starting from one campus in Warden Woods, it grew to three campuses across Scarborough (and two others located in East York and North York).

December 7, 1995: Decree concerning the responsibilities of the Minister Delegate for Employment. June 6, 1996: Manifesto for gender parity published in L'Express; ten women, including former prominent ministers, are its authors. July 5, 1996: Law concerning adoption. January 14, 1997: Publication of selected excerpts from lawyer Gisèle Halimi's report to the Prime Minister on gender inequalities (social, economic, political), which undermine aspects of democracy; the report also proposes various solutions to reduce these inequalities and promote better democracy. June 11, 1997: Decree concerning the responsibilities of the Minister of Employment and Solidarity. December 19, 1997: Social Security Financing Law for 1998; it includes provisions relating to the family. March 8, 1998: Circular concerning the feminization of job titles, functions, ranks, or titles. March 16, 1998: Law concerning nationality. May 11, 1998: Law concerning the entry and residence of foreigners in France and the right of asylum. June 17, 1998: Constitutional bill for gender equality, including possibilities for measures promoting gender parity in political positions. June 17, 1998: Law concerning the prevention and repression of sexual offenses and the protection of minors. November 17, 1998: A State Secretariat for Women's Rights and Vocational Training is delegated to the Ministry of Employment and Solidarity. December 23, 1998: Social Security Financing Law for 1999, notably modifying certain elements relating to family allowances and the back-to-school allowance.

Sources: en.wikipedia.org

Frequently asked questions

How is SR9009 measured in samples?

The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.

What storage conditions are typical for SR9009?

Solid material is usually kept at -20 °C, desiccated, and protected from light. Dimethyl sulfoxide stocks should be stored cold and subjected to minimal freeze-thaw cycles. Aqueous solutions are generally less stable and should be prepared fresh when possible.

Is SR9009 legal to buy?

Legality depends on the country and the intended use. It is not an approved medicine, and some places restrict or ban sales for human consumption. Buyers should verify local rules and product documentation before procurement.

What is SR9009?

It is a synthetic REV-ERB agonist used mainly in preclinical research. It is not an approved medicine for human use.

Network